In this video, Steven Pavletic, MD, MS, from the National Cancer Institute, Bethesda, MD, speaks at the European Society for Blood and Marrow Transplantation (EBMT) 2018 Annual Meeting, held in Lisbon, Portugal, and outlines the salvage therapy options for steroid-refractory chronic graft-versus-host disease (GvHD).
Salvage therapy for chronic GvHD: new approvals
